Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability
The oral administration of non-toxigenic strains of Clostridioides difficile (NTCD) is currently showing promising results for the prevention of Clostridioides difficile infection (CDI) in humans and animals, and is being considered as a possible commercial product to be used in the near future. The aim of this work was to evaluate five culture media for the growth and sporulation of one NTCD (Z31) and evaluate the viability of a lyophilized spore solution of NTCD Z31 stored at 4 °C or at 25 °C for 2 years. Reinforced clostridial medium (RCM) and brain heart infusion broth (BHI) provided the highest production of NTCD Z31 spores. In the first 6 months of the storage of the lyophilized solution, a reduction in spore count of approximately 0.3 Log10 CFU/mL was observed; however, no further significant reduction in spore count was observed up to 24 months. No difference in spore concentration was found between the two storage temperatures from 6 to 24 months of storage. The present work showed BHI and RCM to be the best choices for the growth and sporulation of NTCD Z31 and suggested that the spores of NTCD Z31 are stable for up to 2 years under both temperature conditions.
KeywordsProbiotic Culture media Long-term viability Spores
The authors would like to thank PRPq-UFMG, Fapemig, Capes/Proex, and CNPq for providing financial support in this work.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 7.Silva ROS, Salvarani FM, Cruz Júnior ECC, Pires PS, Santos RLS, Assis RA, Guedes RMC, Lobato FCF (2011) Detection of toxins A/B and isolation of Clostridium difficile from piglets in Brazil. Cienc Rural 41(8):1130–1135Google Scholar
- 18.Nagaro KJ, Phillips ST, Cheknis AK, Sambol SP, Zukowski WE, Johnson S, Gerding DN (2013) Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob Agents Chemother 57(11):5266–5270CrossRefGoogle Scholar
- 19.Gerding DN, Meyer T, Lee C, Cohen SH, Murthy UK, Poirier A, Van Schooneveld TC, Pardi DS, Ramos A, Barron MA, Chen H, Villano S (2015) Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 313(17):1719–1727CrossRefGoogle Scholar
- 26.Atlas RM (1946) Handbook of microbiological media. 4th ed. CRC Press, MiamiGoogle Scholar
- 37.Edwards AN, Suárez JM, McBride SM (2013) Culturing and maintaining Clostridium difficile in an anaerobic environment. J Vis Exp 79:e50787Google Scholar
- 48.Milošević MB, Medić-Pap SS, Ignjatov MV, Petroviã DN (2007) Lyophilization as a method for pathogens long term preservation. Proc Nat Sci 113:203–210Google Scholar